DTIL
DTIL
NASDAQ · Biotechnology

Precision Biosciences Inc

$6.24
+0.02 (+0.32%)
As of Sep 28, 10:23 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +391.8% upside
Low Target $21.79
Average Target $30.69
High Target $37.55
Current Price $6.24
Current
$6.24
Target
$30.69
$21.79 $30.69 avg $37.55
Scenario Analysis
Bear Case
$21.79
249.2%
Low target
Base Case
$30.69
+391.8%
Avg target
Bull Case
$37.55
+501.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$9.62
-35.1% from high
52-Week Low
$3.53
+76.8% from low
Target vs 52W High
$30.69
+219.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%